Traditional Chinese Medicine Intervention for Ischemic Cardiovascular Disease Comorbid With Diabetes Mellitus: An Efficacy Comparative Study
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 4205 participants.
Also called NCT07088523
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 4,205 participants
- Registry
-
NCT07088523
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07088523. Non-randomized; no masking; primary purpose treatment. Start 2025-07-31 (anticipated); primary completion 2026-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Traditional Chinese Medicine Intervention for Ischemic Cardiovascular Disease Comorbid With Diabetes Mellitus: An Efficacy Comparative Study
- Acronym
- TICDEs
- Condition
- Diabete Mellitus
- Condition
- Ischemic Cardiovascular Disease
- Intervention (Drug)
- Xintong Oral Liquid (Sequential Phase)
- Intervention (Drug)
- Xintong Oral Liquid (Intensive Phase)
- Intervention (Drug)
- TCM Syndrome Differentiation Decoction
- Intervention (Drug)
- Standard Treatment (Guideline-Based)
- Lead sponsor
- Guangzhou University of Traditional Chinese Medicine
Record details
- Record id
cardio:ct-nct07088523- Content hash
5c214d50c5a78f7999c0ea8bfda80974e5f6387d988965a44e376f50969009a4